J. Legler

发表

Assessing Comorbidity Using Claims Data: An Overview

C. Klabunde, J. Warren, J. Legler, 2002, Medical care.

Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial.

N L Geller, T Brott, J. Grotta, 1996, Stroke.

Development of a comorbidity index using physician claims data.

J L Warren, C. Klabunde, J. Warren, 2000, Journal of clinical epidemiology.

Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.

Peter H Gann, Eric J Feuer, Ruth Etzioni, 2002, Journal of the National Cancer Institute.

Predicting patterns of mammography use: a geographic perspective on national needs for intervention research.

J. Legler, N. Breen, H. Meissner, 2002, Health services research.

Latent Variable Models for Teratogenesis Using Multiple Binary Outcomes

Louise Ryan, L. Ryan, J. Legler, 1997 .

Anticonvulsant teratogenesis: 2. Statistical methods for multiple birth outcomes.

L. Holmes, J. Legler, L. Ryan, 1994, Teratology.

Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.

Pamela A. Shaw, Ruth Etzioni, J. Legler, 2002, Urology.

AMBIGUITIES IN CALCULATING CANCER PATIENT SURVIVAL : THE SEER EXPERIENCE FOR COLORECTAL AND PROSTATE CANCER

E. Feuer, L. Ries, J. Legler, 2003 .

A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.

C. Klabunde, J. Warren, J. Legler, 2007, Annals of epidemiology.

Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

E. Feuer, P. Prorok, R. Hayes, 1999, Journal of the National Cancer Institute.

Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality.

E. Feuer, Ruth Etzioni, B. Hankey, 1999, Journal of the National Cancer Institute.

Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.

R A Stephenson, P C Albertsen, J. Stanford, 2000, Journal of the National Cancer Institute.

The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence declinein the United States

E. Feuer, B. Kramer, J. Legler, 1998, Cancer Causes & Control.

Accounting for model uncertainty in estimating global burden of disease.

J. Legler, D. Vock, David McClure, 2011, Bulletin of the World Health Organization.

Latent Variable Models for Mixed Discrete and Continuous Outcomes

L. Ryan, J. Legler, M. Sammel, 1997 .

Core symptoms that discriminate premenstrual syndrome.

J. Legler, K. Rickels, Hui Lin, 2011, Journal of women's health.

Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality.

E F Heineman, J L Warren, L. Ries, 1999, Journal of the National Cancer Institute.

Symbolic play in childhood: Interpersonal and environmental context and stability

M. Bornstein, K. Painter, J. Legler, 1997 .

Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study.

J. Stanford, F. Gilliland, J. Liff, 1999, Journal of the National Cancer Institute.

Breast and cervical cancer screening interventions: an assessment of the literature.

B. Edwards, J. Legler, N. Breen, 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

The effectiveness of interventions to promote mammography among women with historically lower rates of screening.

B. Rimer, J. Legler, N. Breen, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Social and behavioral interventions to increase breast cancer screening.

B. Rimer, J. Legler, N. Breen, 2001 .

A comparison of one-sided methods to identify significant individual outcomes in a multiple outcome setting: stepwise tests or global tests with closed testing.

J. Troendle, J. Legler, 1998, Statistics in medicine.

Applying Japanese Lesson Study Principles to an Upper-level Undergraduate Statistics Course

B. Chance, J. Legler, P. Roback, 2006 .

Validation study of retrospective recall of disease-targeted function: results from the prostate cancer outcomes study.

J. Stanford, F. Gilliland, J. Legler, 2000, Medical care.

ICSH recommendations for the analysis of red cell, white cell and platelet size distribution curves. Methods for fitting a single reference distribution and assessing its goodness of fit

R. Verwilghen, C. McLaren, J. Legler, 2008 .

Efficiency and power of tests for multiple binary outcomes

Louise Ryan, L. Ryan, J. Legler, 1995 .

RESPONSE: re: brain and other central nervous system cancers: recent trends in incidence and mortality

Linet, R. Kaplan, J. Warren, 1999, Journal of the National Cancer Institute.

RESPONSE: Re: Brain and Other Central Nervous System Cancers: Recent Trends in Incidence and Mortality.

Linet, J. Warren, J. Legler, 1999, Journal of the National Cancer Institute.

Assessing uncertainty in microsimulation modelling with application to cancer screening interventions.

K A Cronin, J M Legler, R D Etzioni, 1998, Statistics in medicine.

COMMENTARY Prostate Cancer Practice Patterns and Quality of Life: the Prostate Cancer Outcomes Study

J. Liff, J. Legler, J. Eley, 1999 .